Gyeonggi-do, South Korea

Yeon Jung Song

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Yongon-si, KR (2014)
  • Yongin-si, KR (2015)
  • Suwon-si, KR (2011 - 2018)
  • Gyeonggi-do, KR (2014 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Yeon Jung Song: Innovator in Autoimmune Disease Treatment

Introduction

Yeon Jung Song is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for autoimmune diseases. With a total of 10 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of Yeon Jung Song's latest patents involves an isolated anti-FcRn antibody. This antibody binds to the neonatal Fc receptor (FcRn), which has a high affinity for immunoglobulin G (IgG) or its fragments. The patent describes a method of preparing this antibody, a composition for treating autoimmune diseases that includes the antibody, and methods for treating and diagnosing these diseases. The FcRn-specific antibody binds to FcRn non-competitively with IgG, effectively reducing serum pathogenic auto-antibody levels. This innovative approach can be utilized for the treatment of various autoimmune diseases.

Career Highlights

Throughout his career, Yeon Jung Song has worked with notable companies in the biotechnology sector. He has been associated with Hanall Biopharma Co., Ltd. and Immunomet Therapeutics Inc. His experience in these organizations has contributed to his expertise in developing therapeutic solutions.

Collaborations

Yeon Jung Song has collaborated with several professionals in his field, including Sung Wuk Kim and Seung Kook Park. These collaborations have likely enhanced his research and development efforts.

Conclusion

Yeon Jung Song is a distinguished inventor whose work in antibody development for autoimmune diseases showcases his innovative spirit and dedication to improving healthcare. His contributions are paving the way for new treatment options in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…